Patents by Inventor Chao-Min Hsu

Chao-Min Hsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITING ANGIOGENESIS
    Publication number: 20240316144
    Abstract: The present invention provides a method for inhibiting angiogenesis in a subject, which comprises administering said subject a pharmaceutical composition comprising beauvericin at a therapeutically effective concentration ranging from 0.1 ?M to 5 ?M. Also provides is the pharmaceutical composition comprising beauvericin at a therapeutically effective concentration ranging from 0.1 ?M to 5 ?M, and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: February 6, 2024
    Publication date: September 26, 2024
    Applicant: ZIH YUAN TANG Biotechnology Co, Ltd.
    Inventors: Ming-Jai SU, Shoei-Sheng LEE, Feng-Chiao TSAI, Hou-Jen CHEN, Chao-Min HSU
  • Method for treating ocular diseases
    Patent number: 11033603
    Abstract: The present invention provides a method for treating an ocular disease such as age-related macular degeneration (AMD), diabetic retinopathy (DR) or macular edema (ME), which comprises administering to a subject in need thereof a composition comprising a therapeutically effective amount of beauvericin.
    Type: Grant
    Filed: April 1, 2020
    Date of Patent: June 15, 2021
    Assignee: ZIH YUAN TANG BIOTECHNOLOGY CO., LTD.
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Lung-Jr Lin, Chao-Min Hsu
  • METHOD FOR TREATING OCULAR DISEASES
    Publication number: 20200316165
    Abstract: The present invention provides a method for treating an ocular disease such as age-related macular degeneration (AMD), diabetic retinopathy (DR) or macular edema (ME), which comprises administering to a subject in need thereof a composition comprising a therapeutically effective amount of beauvericin.
    Type: Application
    Filed: April 1, 2020
    Publication date: October 8, 2020
    Applicant: ZIH YUAN TANG Biotechnology Co., Ltd.
    Inventors: Shoei-Sheng LEE, Ming-Jai SU, Lung-Jr LIN, Chao-Min HSU
  • NEW USE OF ISOQUINOLINE DERIVATIVES FOR WOUND HEALING
    Publication number: 20190224187
    Abstract: The present invention is related to a method for wound healing comprising administering to a subject in need thereof a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably salsolinol.
    Type: Application
    Filed: January 22, 2019
    Publication date: July 25, 2019
    Applicant: ZIH YUAN TANG Biotechnology Co., Ltd
    Inventors: Ming-Jai SU, Shoei-Sheng LEE, Chao-Min HSU
  • Isoquinoline alkaloid derivative for activating AMP-dependent protein kinase
    Patent number: 9707222
    Abstract: The present invention provides a method for activating the AMP-dependent protein kinase (AMPK) in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably salsolinol or reticuline. The pharmaceutical composition is able to activate AMPK, and thus is effective in the regulation of cell growth and metabolism, and the treatment of AMPK associated diseases.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: July 18, 2017
    Assignee: ZIH YUAN TANG BIOTECHNOLOGY CO., LTD.
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Chi-Huan Yeh, Sheng-Fa Tsai, Cheng-Yen Tsai, Chi-Tun Ruan, Chao-Min Hsu
  • Use of isoquinoline derivatives for diabetic wound healing
    Patent number: 9655891
    Abstract: The present invention is related to a method for diabetic wound healing comprising administering to a subject in need thereof a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably salsolinol.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: May 23, 2017
    Assignee: ZIH YUAN TANG BIOTECHNOLOGY CO., LTD
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Chi-Huan Yeh, Chao-Min Hsu
  • SECOAPORPHINE ALKALOID DERIVATIVE FOR ACTIVATING AMP-DEPENDENT PROTEIN KINASE
    Publication number: 20150342908
    Abstract: The present invention provides a method for activating the AMP-dependent protein kinase (AMPK) in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably 1,10-dihydroxyaporphine. The pharmaceutical composition is able to activate AMPK, and thus is effective in the regulation of cell growth and metabolism, and the treatment of AMPK associated diseases.
    Type: Application
    Filed: September 22, 2014
    Publication date: December 3, 2015
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Chi-Huan Yeh, Cheng-Yen Tsai, Chi-Tun Ruan, Chao-Min Hsu
  • APORPHINE ALKALOID DERIVATIVE FOR ACTIVATING AMP-DEPENDENT PROTEIN KINASE
    Publication number: 20150342933
    Abstract: The present invention provides a method for activating the AMP-dependent protein kinase (AMPK) in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably 1,10-dihydroxyaporphine. The pharmaceutical composition is able to activate AMPK, and thus is effective in the regulation of cell growth and metabolism, and the treatment of AMPK associated diseases.
    Type: Application
    Filed: September 22, 2014
    Publication date: December 3, 2015
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Chi-Huan Yeh, Cheng-Yen Tsai, Chi-Tun Ruan, Chin-Ting Lin, Chao-Min Hsu
  • ISOQUINOLINE ALKALOID DERIVATIVE FOR ACTIVATING AMP-DEPENDENT PROTEIN KINASE
    Publication number: 20150335634
    Abstract: The present invention provides a method for activating the AMP-dependent protein kinase (AMPK) in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably salsolinol or reticuline. The pharmaceutical composition is able to activate AMPK, and thus is effective in the regulation of cell growth and metabolism, and the treatment of AMPK associated diseases.
    Type: Application
    Filed: September 22, 2014
    Publication date: November 26, 2015
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Chi-Huan Yeh, Sheng-Fa Tsai, Cheng-Yen Tsai, Chi-Tun Ruan, Chao-Min Hsu